Frankenfield Christopher James
Chief Financial Officer at XLO
- Sold, on record
- $11k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jan 2, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XLOXilio Therapeutics, Inc.Chief Financial Officer
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 4 sale XLORoutineJan 2, 2025 2025
Sold 6,954 shares at $0.98 ($7k)
Frankenfield Christopher James, Chief Financial Officer
10b5-1 planSold 35.9% of holdings ($19k position)12,421 shares leftFirst sale on recordFiling
- 2 Form 4 sale XLORoutineJan 2, 2026 +365 days
Sold 7,030 shares at $0.64 ($4k)
Frankenfield Christopher James, Chief Financial Officer
10b5-1 planSold 22.1% of holdings ($20k position)24,766 shares leftFiling
Every transaction
Loading transactions…